These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 16242892)

  • 1. Isolation and identification of novel impurities in spironolactone.
    Chen H; Wang YF; Yang ZD; Li YC
    J Pharm Biomed Anal; 2006 Mar; 40(5):1263-7. PubMed ID: 16242892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation and identification of a sulfur-containing metabolite of spironolactone from human urine.
    Koch K; Senn M; Steingross W
    Steroids; 1976 Oct; 28(4):467-80. PubMed ID: 1006719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitro derivatives from the Arctic ice bacterium Salegentibacter sp. isolate T436.
    Schuhmann I; Yao CB; Al-Zereini W; Anke H; Helmke E; Laatsch H
    J Antibiot (Tokyo); 2009 Aug; 62(8):453-60. PubMed ID: 19644517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural identification and characterization of impurities in moxifloxacin.
    Kumar YR; Prasad Raju VV; Kumar RR; Eswaraiah S; Mukkanti K; Suryanarayana MV; Reddy MS
    J Pharm Biomed Anal; 2004 Mar; 34(5):1125-9. PubMed ID: 15019047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation, structural elucidation and characterization of impurities in Cefdinir.
    Rao KV; Rani A; Reddy AV; Bharathi CH; Dandala R; Naidu A
    J Pharm Biomed Anal; 2007 Mar; 43(4):1476-82. PubMed ID: 17174507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification, isolation and characterization of impurities of clindamycin palmitate hydrochloride.
    Bharathi Ch; Jayaram P; Sunder Raj J; Saravana Kumar M; Bhargavi V; Handa VK; Dandala R; Naidu A
    J Pharm Biomed Anal; 2008 Dec; 48(4):1211-8. PubMed ID: 18947955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and characterization of potential impurities of donepezil.
    Krishna Reddy KV; Moses Babu J; Kumar PA; Chandrashekar ER; Mathad VT; Eswaraiah S; Reddy MS; Vyas K
    J Pharm Biomed Anal; 2004 Sep; 35(5):1047-58. PubMed ID: 15336352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel spironolactone-analogs as impurities in spironolactone.
    Chen H; Wang XY; Yang ZD; Li YC
    Steroids; 2004 Sep; 69(10):647-52. PubMed ID: 15465109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lanostanes and friedolanostanes from the bark of Garcinia speciosa.
    Vieira LM; Kijjoa A; Silva AM; Mondranondra IO; Kengthong S; Gales L; Damas AM; Herz W
    Phytochemistry; 2004 Feb; 65(4):393-8. PubMed ID: 14759530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impurity profile study of dutasteride.
    Satyanarayana K; Srinivas K; Himabindu V; Mahesh Reddy G
    Pharmazie; 2007 Oct; 62(10):743-6. PubMed ID: 18236777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [THIN-LAYER CHROMATOGRAPHIC STUDIES OF 3'-(3-OXO-7-ALPHA-ACETYLTHIO-17-BETA-HYDROXY-4-ANDROSTEN-17-ALPHA-YL)-PROPIONIC ACID GAMMA-LACTONE AND ITS METABOLITES IN MAN].
    ZICHA L; WEIST F; SCHEIFFARTH ; SCHMID E
    Arzneimittelforschung; 1964 Jun; 14():699-705. PubMed ID: 14249070
    [No Abstract]   [Full Text] [Related]  

  • 12. Structural characterization of impurities in pioglitazone.
    Kumar YR; Reddy AR; Eswaraiah S; Mukkanti K; Reddy MS; Suryanarayana MV
    Pharmazie; 2004 Nov; 59(11):836-9. PubMed ID: 15587582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New triterpenic saponins from the aerial parts of Medicago arabica (L.) huds.
    Tava A; Mella M; Avato P; Biazzi E; Pecetti L; Bialy Z; Jurzysta M
    J Agric Food Chem; 2009 Apr; 57(7):2826-35. PubMed ID: 19256537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and characterization of some potential impurities in ropinirole hydrochloride.
    Sahasrabuddhey B; Nautiyal R; Acharya H; Khyade S; Luthra PK; Deshpande PB
    J Pharm Biomed Anal; 2007 Mar; 43(4):1587-93. PubMed ID: 17207602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural studies of racecadotril and its process impurities by NMR and mass spectroscopy.
    Reddy KM; Babu JM; Sudhakar P; Sharma MS; Reddy GS; Vyas K
    Pharmazie; 2006 Dec; 61(12):994-8. PubMed ID: 17283655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [ON THE METABOLISM OF 3-(3-OXO-7-ALPHA-ACETYLTHIO-17-BETA-HYDROXY-4-ANDROSTEN-17-ALPHA-YL)-PROPIONIC ACID-GAMMA-LACTONE].
    GERHARDS E; ENGELHARDT R
    Arzneimittelforschung; 1963 Nov; 13():972-7. PubMed ID: 14216044
    [No Abstract]   [Full Text] [Related]  

  • 17. Identification, synthesis, isolation and spectral characterization of potential impurities of montelukast sodium.
    Saravanan M; Siva Kumari K; Pratap Reddy P; Naidu MN; Moses Babu J; Srivastava AK; Lakshmi Kumar T; Chandra Sekhar BV; Satyanarayana B
    J Pharm Biomed Anal; 2008 Nov; 48(3):708-15. PubMed ID: 18755563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification, isolation and characterization of process-related impurities in Rizatriptan benzoate.
    Raj TJ; Bharathi Ch; Kumar MS; Prabahar J; Kumar PN; Sharma HK; Parikh K
    J Pharm Biomed Anal; 2009 Jan; 49(1):156-62. PubMed ID: 19056198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variable temperature X-ray powder diffractometry of spironolactone polymorphs.
    Liebenberg W; van Tonder EC; Dekker TG; de Villiers MM
    Pharmazie; 2003 Jun; 58(6):435-7. PubMed ID: 12857015
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.